Early administration of ritonavir-boosted lopinavir could prevent severe COVID-19

No specific treatment against SARS-CoV-2 is available after 6 months of COVID-19 worldwide outbreakAntivirals could decrease the viral load and reduce direct and indirect damages of SARSCoV-2 infectionRitonavir-bosted lopinavir is effective against SARS-CoV-2 in vitroSequential virological and pharmacological monitoring helped to understand the efficacy of ritonavir-boosted lopinavir in a SARS-CoV-2 infected patientRitonavir-boosted lopinavir could be proposed as early treatment for SARS-CoV-2 infection
Source: Journal of Infection - Category: Infectious Diseases Authors: Tags: Virology and pharmacology of LPV/r in SARS-CoV-2-infected patient Source Type: research